Integrative oncology meets immunotherapy: New prospects for combination therapy grounded in Eastern medical knowledge
Integrative oncology meets immunotherapy: New prospects for combination therapy grounded in Eastern medical knowledge
复制标题
DOI：
10.1007/s11655-012-1201-0
复制
发表时间：
2012-09-01
影响因子：
2.9
通讯作者：
Bodeker, Gerard
中科院分区：
文献类型：
--
作者：
Bodeker, Gerard
随着全球癌症发病率上升，标准护理受到质疑。涉及免疫疗法的新方法正在出现。随着这种转变，草药和提取物的使用和潜力也发生了相应的转变。本文源自第二届北京国际中西医结合医学研讨会（BISIM，2012 年 5 月 19 日至 20 日）上的演讲，重点关注中医，但也可推广到更广泛的东方医学和其他草药传统。直到最近，草药和相关治疗一直被用作传统护理的辅助剂，以减少副作用、增强细胞毒性，有时甚至会抵消化疗和放疗的疗效。现在，在新型免疫癌症疗法的背景下，草药和其他补充疗法被视为身体免疫力的增强剂。
As cancer rates rise globally, standard care is being questioned; new approaches involving immune therapies are emerging. With this shift comes a corresponding shift in the use and potential of herbal medicines and extracts. The focus of this article, which has evolved from a presentation at the Second Beijing International Symposium on Integrative Medicine (BISIM May 19-20, 2012), is particularly on Chinese medicine, but is generalizable to Eastern medicine more broadly and to other herbal traditions. Until recently, herbal and related treatments have been used as adjuvants to conventional care - for reducing side-effects, enhancing cytotoxicity, and sometimes, undesirably counteracting the efficacy of chemotherapy and radiation. Now, in the context of a new class of immune-based cancer therapies, herbal and other complementary modalities are looked at as enhancers of the body's immunity.